P04.46 Variable RNA sequencing depth impacts gene signatures and target compound robustness - case study examining brain tumour (glioma) disease progression

BACKGROUND: Gene expression profiling can uncover biological mechanisms underlying disease and is important in drug development. RNA-seq is routinely used to assess gene expression but costs remain high. Sample multiplexing reduces RNA-seq costs, however, multiplexed samples have lower cDNA sequenci...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Stupnikov, A, McInerney, C E, O’Reilly, P G, Roddy, A C, Dunne, P D, Gilmore, A, Savage, K, McIntosh, S A, Flannery, T, Healy, E, Ellis, H P, Kurian, K M, Emmert-Streib, F, Prise, K M, Salto-Tellez, M, McArt, D G
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Poster Presentations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144694/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.280
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller